Cardiac Cachexia: A Well-Known but Challenging Complication of Heart Failure

References

• Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 2008;52(6):428–434. doi:10.1016/j.jacc.2008.03.06118672162
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Anker SD, AlHabib KF, et al. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 2014;1(1):4–25. doi:10.1002/ehf2.1200528834669
   PubMedGoogle Scholar
• von Haehling S, Doehner W, Anker SD. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res. 2007;73(2):298–309. doi:10.1016/j.cardiores.2006.08.01817034772
   PubMed Web of Science ®Google Scholar
• Springer J, Anker SD. Publication trends in cachexia and sarcopenia in elderly heart failure patients. Wien Klin Wochenschr. 2016;128(Suppl S7):446–454. doi:10.1007/s00508-016-1126-227885423
   PubMed Web of Science ®Google Scholar
• von Haehling S, Anker SD. Prevalence, incidence and clinical impact of cachexia: facts and numbers—update 2014. J Cachexia Sarcopenia Muscle. 2014;5(4):261–263. doi:10.1007/s13539-014-0164-825384990
   PubMed Web of Science ®Google Scholar
• Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96(2):526–534. doi:10.1161/01.cir.96.2.5269244221
   PubMed Web of Science ®Google Scholar
• Okoshi MP, Capalbo RV, Romeiro FG, Okoshi K. Cardiac cachexia: perspectives for prevention and treatment. Arq Bras Cardiol. 2017;108(1):74–80. doi:10.5935/abc.2016014227812676
   PubMed Web of Science ®Google Scholar
• Wleklik M, Uchmanowicz I, Jankowska-Polańska B, Andreae C, Regulska-Ilow B. The role of nutritional status in elderly patients with heart failure. J Nutr Health Aging. 2018;22(5):581–588. doi:10.1007/s12603-017-0985-129717757
   PubMed Web of Science ®Google Scholar
• Wang C, Dong X, Wei L, et al. The relationship of appetite-regulating hormones in the development of cardiac cachexia. Int Heart J. 2019;60(2):384–391. doi:10.1536/ihj.18-13130799377
   PubMed Web of Science ®Google Scholar
• von Haehling S, Anker MS, Anker SD. Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016. J Cachexia Sarcopenia Muscle. 2016;7(5):507–509. doi:10.1002/jcsm.1216727891294
   PubMed Web of Science ®Google Scholar
• Anker SD, Negassa A, Coats AJS, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361(9363):1077–1083. doi:10.1016/S0140-6736(03)12892-912672310
   PubMed Web of Science ®Google Scholar
• Loncar G, Springer J, Anker M, Doehner W, Lainscak M. Cardiac cachexia: hic et nunc. J Cachexia Sarcopenia Muscle. 2016;7(3):246–260. doi:10.1002/jcsm.1211827386168
   PubMed Web of Science ®Google Scholar
• Anker SD, Morley JE. Cachexia: a nutritional syndrome? J Cachexia Sarcopenia Muscle. 2015;6(4):269–271. doi:10.1002/jcsm.1208826675043
   PubMed Web of Science ®Google Scholar
• von Haehling S. Casting the net broader to confirm our imaginations: the long road to treating wasting disorders. J Cachexia Sarcopenia Muscle. 2017;8(6):870–880. doi:10.1002/jcsm.1225629168628
   PubMed Web of Science ®Google Scholar
• Evans WJ, Morley JE, Argilés J, et al. Cachexia: a new definition. Clin Nutr. 2008;27(6):793–799. doi:10.1016/j.clnu.2008.06.01318718696
   PubMed Web of Science ®Google Scholar
• Lena A, Coats AJS, Anker MS. Metabolic disorders in heart failure and cancer. ESC Heart Fail. 2018;5(6):1092–1098. doi:10.1002/ehf2.1238930570226
   PubMed Web of Science ®Google Scholar
• Lainscak M, von Haehling S, Anker SD. PURE muscle and more. Int J Cardiol. 2016;202:446–447. doi:10.1016/j.ijcard.2015.09.12126433767
   PubMed Web of Science ®Google Scholar
• Araújo JP, Lourenço P, Rocha-Gonçalves F, Ferreira A, Bettencourt P. Nutritional markers and prognosis in cardiac cachexia. Int J Cardiol. 2011;146(3):359–363. doi:10.1016/j.ijcard.2009.07.04219703717
   PubMed Web of Science ®Google Scholar
• Alsafwah S, Laguardia SP, Arroyo M, et al. Congestive heart failure is a systemic illness: a role for minerals and micronutrients. Clin Med Res. 2007;5(4):238–243. doi:10.3121/cmr.2007.73718367709
   PubMedGoogle Scholar
• Doenst T, Abel ED. Spotlight on metabolic remodelling in heart failure. Cardiovasc Res. 2011;90(2):191–193. doi:10.1093/cvr/cvr07721429943
   PubMed Web of Science ®Google Scholar
• Sciatti E, Lombardi C, Ravera A, et al. Nutritional deficiency in patients with heart failure. Nutrients. 2016;8(7):442. doi:10.3390/nu8070442
   Web of Science ®Google Scholar
• McMurray JJV, Dunselman P, Wedel H, et al. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure). J Am Coll Cardiol. 2010;56(15):1196–1204. doi:10.1016/j.jacc.2010.02.07520883926
   PubMed Web of Science ®Google Scholar
• Folkers K, Langsjoen P, Willis R, et al. Lovastatin decreases coenzyme Q levels in humans. Proc Natl Acad Sci U S A. 1990;87(22):8931–8934. doi:10.1073/pnas.87.22.89312247468
   PubMed Web of Science ®Google Scholar
• Witham MD, Crighton LJ, Gillespie ND, Struthers AD, McMurdo MET. The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail. 2010;3(2):195–201. doi:10.1161/CIRCHEARTFAILURE.109.90789920103775
   PubMed Web of Science ®Google Scholar
• Boxer RS, Kenny AM, Schmotzer BJ, Vest M, Fiutem JJ, Piña IL. A randomized controlled trial of high dose vitamin D3 in patients with heart failure. JACC Heart Fail. 2013;1(1):84–90. doi:10.1016/j.jchf.2012.11.00324614995
   PubMed Web of Science ®Google Scholar
• Cohen-Solal A, Leclercq C, Deray G, et al. Iron deficiency: an emerging therapeutic target in heart failure. Heart. 2014;100(18):1414–1420. doi:10.1136/heartjnl-2014-30566924957529
   PubMed Web of Science ®Google Scholar
• Drozd M, Jankowska EA, Banasiak W, Ponikowski P. Iron therapy in patients with heart failure and iron deficiency: review of iron preparations for practitioners. Am J Cardiovasc Drugs. 2017;17(3):183–201. doi:10.1007/s40256-016-0211-228039585
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Anker SD, Horwich TB, Fonarow GC. Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol. 2008;101(11):89E–103E. doi:10.1016/j.amjcard.2008.03.007
   Web of Science ®Google Scholar
• Kamo T, Akazawa H, Suzuki J, Komuro I. Novel concept of a heart-gut axis in the pathophysiology of heart failure. Korean Circ J. 2017;47(5):663–669. doi:10.4070/kcj.2017.002828955383
   PubMed Web of Science ®Google Scholar
• Pasini E, Aquilani R, Corsetti G, Dioguardi FS. Malnutrition and gut flora dysbiosis: specific therapies for emerging comorbidities in heart failure. Biomed Res Int. 2015;2015:382585. doi:10.1155/2015/38258526491666
   PubMed Web of Science ®Google Scholar
• Horwich TB, Fonarow GC, Clark AL. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis. 2018;61(2):151–156. doi:10.1016/j.pcad.2018.05.00529852198
   PubMed Web of Science ®Google Scholar
• Zamora E, Díez-López C, Lupón J, et al. Weight loss in obese patients with heart failure. J Am Heart Assoc. 2016;5(3):e002468. doi:10.1161/JAHA.115.00246827013541
   PubMed Web of Science ®Google Scholar
• Mariotti R, Castrogiovanni F, Canale ML, Borelli G, Rondinini L. Weight loss and quality of life in chronic heart failure patients. J Cardiovasc Med (Hagerstown). 2008;9(6):576–580. doi:10.2459/JCM.0b013e3282f2de1318475125
   PubMed Web of Science ®Google Scholar
• Padwal R, McAlister FA, McMurray JJV, et al. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond). 2014;38(8):1110–1114. doi:10.1038/ijo.2013.20324173404
   PubMed Web of Science ®Google Scholar
• Oga EA, Eseyin OR. The obesity paradox and heart failure: a systematic review of a decade of evidence. J Obes. 2016;2016:1–9. doi:10.1155/2016/9040248
   Google Scholar
• Martins T, Vitorino R, Moreira-Gonçalves D, Amado F, Duarte JA, Ferreira R. Recent insights on the molecular mechanisms and therapeutic approaches for cardiac cachexia. Clin Biochem. 2014;47(1–2):8–15. doi:10.1016/j.clinbiochem.2013.10.02524184665
   PubMed Web of Science ®Google Scholar
• Attanasio P, Anker SD, Doehner W, von Haehling S. Hormonal consequences and prognosis of chronic heart failure. Curr Opin Endocrinol Diabetes Obes. 2011;18(3):224–230. doi:10.1097/MED.0b013e328346950521494135
   PubMedGoogle Scholar
• Yoshida T, Tabony AM, Galvez S, et al. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia. Int J Biochem Cell Biol. 2013;45(10):2322–2332. doi:10.1016/j.biocel.2013.05.03523769949
   PubMed Web of Science ®Google Scholar
• Yoshida T, Delafontaine P. Mechanisms of cachexia in chronic disease states. Am J Med Sci. 2015;350(4):250–256. doi:10.1097/MAJ.000000000000051126083652
   PubMed Web of Science ®Google Scholar
• von Haehling S, Schefold JC, Lainscak M, Doehner W, Anker SD. Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders. Heart Fail Clin. 2009;5(4):549–560. doi:10.1016/j.hfc.2009.04.00119631179
   PubMedGoogle Scholar
• Aukrust P, Ueland T, Lien E, et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1999;83(3):376–382. doi:10.1016/s0002-9149(98)00872-810072227
   PubMed Web of Science ®Google Scholar
• Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005;112(12):1756–1762. doi:10.1161/CIRCULATIONAHA.104.53097216157772
   PubMed Web of Science ®Google Scholar
• Scherbakov N, Bauer M, Sandek A, et al. Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail. 2015;17(10):1015–1021. doi:10.1002/ejhf.31726198713
   PubMed Web of Science ®Google Scholar
• Korek E, Krauss H, Gibas-Dorna M, Kupsz J, Piątek M, Piątek J. Fasting and postprandial levels of ghrelin, leptin and insulin in lean, obese and anorexic subjects. Prz Gastroenterol. 2013;8(6):383–389. doi:10.5114/pg.2013.3992224868288
   PubMed Web of Science ®Google Scholar
• Yoshida T, Semprun-Prieto L, Sukhanov S, Delafontaine P. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression. Am J Physiol Heart Circ Physiol. 2010;298(5):H1565–H1570. doi:10.1152/ajpheart.00146.201020228261
   PubMed Web of Science ®Google Scholar
• Tatsumi R. Mechano-biology of skeletal muscle hypertrophy and regeneration: possible mechanism of stretch-induced activation of resident myogenic stem cells. Anim Sci J. 2010;81(1):11–20. doi:10.1111/j.1740-0929.2009.00712.x20163667
   PubMed Web of Science ®Google Scholar
• Sanders PM, Russell ST, Tisdale MJ. Angiotensin II directly induces muscle protein catabolism through the ubiquitin–proteasome proteolytic pathway and may play a role in cancer cachexia. Br J Cancer. 2005;93(4):425–434. doi:10.1038/sj.bjc.660272516052213
   PubMed Web of Science ®Google Scholar
• Morley JE. Treatment of sarcopenia: the road to the future. J Cachexia Sarcopenia Muscle. 2018;9(7):1196–1199. doi:10.1002/jcsm.1238630697982
   PubMed Web of Science ®Google Scholar
• Saitoh M, Ishida J, Doehner W, et al. Sarcopenia, cachexia, and muscle performance in heart failure: review update 2016. Int J Cardiol. 2017;238:5–11. doi:10.1016/j.ijcard.2017.03.15528427849
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in older people. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq03420392703
   PubMed Web of Science ®Google Scholar
• Tyrovolas S, Koyanagi A, Olaya B, et al. Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi‐continent study. J Cachexia Sarcopenia Muscle. 2016;7(3):312–321. doi:10.1002/jcsm.1207627239412
   PubMed Web of Science ®Google Scholar
• Szulc P, Feyt C, Chapurlat R. High risk of fall, poor physical function, and low grip strength in men with fracture—the STRAMBO study. J Cachexia Sarcopenia Muscle. 2016;7(3):299–311. doi:10.1002/jcsm.1206627239407
   PubMed Web of Science ®Google Scholar
• Uchmanowicz I, Łoboz-Rudnicka M, Szeląg P, Jankowska-Polańska B, Łoboz-Grudzień K. Frailty in heart failure. Curr Heart Fail Rep. 2014;11(3):266–273. doi:10.1007/s11897-014-0198-424733407
   PubMedGoogle Scholar
• Yamada S, Kamiya K, Kono Y. Frailty may be a risk marker for adverse outcome in patients with congestive heart failure. ESC Heart Fail. 2015;2(3):168–170. doi:10.1002/ehf2.1205228834671
   PubMedGoogle Scholar
• Lomivorotov VV, Efremov SM, Boboshko VA, et al. Evaluation of nutritional screening tools for patients scheduled for cardiac surgery. Nutrition. 2013;29(2):436–442. doi:10.1016/j.nut.2012.08.00623200301
   PubMed Web of Science ®Google Scholar
• Suzuki T, Palus S, Springer J. Skeletal muscle wasting in chronic heart failure. ESC Heart Fail. 2018;5(6):1099–1107. doi:10.1002/ehf2.1238730548178
   PubMed Web of Science ®Google Scholar
• Harris R, Chang Y, Beavers K, et al. Risk of fracture in women with sarcopenia, low bone mass, or both. J Am Geriatr Soc. 2017;65(12):2673–2678. doi:10.1111/jgs.1505028960230
   PubMed Web of Science ®Google Scholar
• Ebner N, von Haehling S. Unlocking the wasting enigma: highlights from the 8th cachexia conference. J Cachexia Sarcopenia Muscle. 2016;7(1):90–94. doi:10.1002/jcsm.1210627128291
   PubMed Web of Science ®Google Scholar
• Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population‐based sample of community‐dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290–298. doi:10.1002/jcsm.1207327239410
   PubMed Web of Science ®Google Scholar
• Tieland M, Trouwborst I, Clark BC. Skeletal muscle performance and ageing. J Cachexia Sarcopenia Muscle. 2018;9(1):3–19. doi:10.1002/jcsm.1223829151281
   PubMed Web of Science ®Google Scholar
• Bean N, Bennett KM, Lehmann AB. Habitus and hip fracture revisited: skeletal size, strength and cognition rather than thinness? Age Ageing. 1995;24(6):481–484. doi:10.1093/ageing/24.6.4818588536
   PubMed Web of Science ®Google Scholar
• Gonzalez MC, Heymsfield SB. Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating? J Cachexia Sarcopenia Muscle. 2017;8(2):187–189. doi:10.1002/jcsm.1215928145079
   PubMed Web of Science ®Google Scholar
• Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28–36. doi:10.1002/jcsm.1204827066316
   PubMed Web of Science ®Google Scholar
• Morley JE, Bauer JM. Editorial: the future of sarcopenia. Curr Opin Clin Nutr Metab Care. 2019;22(1):1–3. doi:10.1097/MCO.000000000000053130431471
   PubMed Web of Science ®Google Scholar
• Minaglia C, Giannotti C, Boccardi V, et al. Cachexia and advanced dementia. J Cachexia Sarcopenia Muscle. 2019;10(2):263–277. doi:10.1002/jcsm.1238030794350
   PubMed Web of Science ®Google Scholar
• Vest AR, Chan M, Deswal A, et al. Nutrition, obesity, and cachexia in patients with heart failure: a consensus statement from the Heart Failure Society of America Scientific Statements Committee. J Card Fail. 2019;25(5):380–400. doi:10.1016/j.cardfail.2019.03.00730877038
   PubMed Web of Science ®Google Scholar
• Carbone S, Billingsley HE, Rodriguez-Miguelez P, et al. Lean mass abnormalities in heart failure: the role of sarcopenia, sarcopenic obesity, and cachexia. Curr Probl Cardiol. 2019;100417. doi:10.1016/j.cpcardiol.2019.03.006.31036371
   PubMed Web of Science ®Google Scholar
• Rolfe M, Kamel A, Ahmed MM, Kramer J. Pharmacological management of cardiac cachexia: a review of potential therapy options. Heart Fail Rev. 2019;24(5):617–623. doi:10.1007/s10741-019-09784-330923991
   PubMed Web of Science ®Google Scholar
• Rozentryt P, von Haehling S, Lainscak M, et al. The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study. J Cachexia Sarcopenia Muscle. 2010;1(1):35–42. doi:10.1007/s13539-010-0008-021475692
   PubMed Web of Science ®Google Scholar
• Fumagalli S, Fattirolli F, Guarducci L, et al. Coenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo-controlled, double-blind study. Clin Cardiol. 2011;34(4):211–217. doi:10.1002/clc.2084621462215
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200. doi:10.1093/eurheartj/ehw12827206819
   PubMed Web of Science ®Google Scholar
• Dalla Libera L, Ravara B, Angelini A, et al. Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure. Circulation. 2001;103(17):2195–2200. doi:10.1161/01.cir.103.17.219511331262
   PubMed Web of Science ®Google Scholar
• Clark AL, Coats AJS, Krum H, et al. Effect of beta‐adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial. J Cachexia Sarcopenia Muscle. 2017;8(4):549–556. doi:10.1002/jcsm.1219128244261
   PubMed Web of Science ®Google Scholar
• von Haehling S, Anker SD. The times they are a-changin’: the cachexia conference goes annual. J Cachexia Sarcopenia Muscle. 2016;7(1):3–4. doi:10.1002/jcsm.1211027066313
   PubMed Web of Science ®Google Scholar
• Meleleo D, Bartolomeo N, Cassano L, et al. Evaluation of body composition with bioimpedance. A comparison between athletic and non-athletic children. Eur J Sport Sci. 2017;17(6):710–719. doi:10.1080/17461391.2017.129175028319679
   PubMed Web of Science ®Google Scholar
• Massari F, Scicchitano P, Iacoviello M, et al. Multiparametric approach to congestion for predicting long-term survival in heart failure. J Cardiol. 2020;75(1):47–52. doi:10.1016/j.jjcc.2019.05.01731326239
   PubMed Web of Science ®Google Scholar